Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Roche Holdings ADR RHHBY

Healthcare
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue... see more

Recent & Breaking News (OTCQX:RHHBY)

FDA Grants Breakthrough Therapy Designation for Genentech’s Actemra® (Tocilizumab) in Giant Cell Arteritis, a Form of Vasculitis

Business Wire October 5, 2016

FDA Grants Breakthrough Therapy Designation for Genentech’s Alecensa® (Alectinib) for First-Line Treatment of People with ALK-Positive NSCLC

Business Wire October 4, 2016

Harmony® Prenatal Test for assessment of Down syndrome and other chromosomal disorders receives CE mark

PR Newswire Europe Non Regulatory September 29, 2016

Harmony® Prenatal Test for assessment of Down syndrome and other chromosomal disorders receives CE mark

PR Newswire September 29, 2016

FDA Grants Roche Label Extension for the cobas® EGFR Mutation Test v2 for use with Plasma as a Companion Diagnostic for TAGRISSO™

PR Newswire September 29, 2016

Roche receives 510(k) clearance from FDA for Treponema pallidum assay to aid clinicians in the diagnosis of syphilis infection

PR Newswire September 26, 2016

Roche launches low-cost PT/INR home monitoring app

PR Newswire September 26, 2016

Phase III Efficacy Results of Investigational Medicine OCREVUS™ (Ocrelizumab) Reinforced by Exploratory Analyses in Two Forms of Multiple Sclerosis

Business Wire September 14, 2016

Phase III Study Showed Genentech’s Cancer Immunotherapy TECENTRIQ™ (Atezolizumab) Helped People with a Specific Type of Lung Cancer Live Significantly Longer Compared to Chemotherapy

Business Wire September 1, 2016

Roche receives FDA Emergency Use Authorization for Zika PCR test

PR Newswire August 29, 2016

Following Pfizer's Q2 Results, Citi Says Investors Remain Focused On Potential Breakup

Benzinga.com  August 2, 2016

Roche launches new target enrichment systems for genetic and translational research

PR Newswire Europe Non Regulatory August 2, 2016

Roche HIV Global Access Program expands to include next-generation automated platform solutions

PR Newswire Europe Non Regulatory July 20, 2016

Genentech Provides Update on Phase III Study of Gazyva® in People With Previously Untreated Diffuse Large B-Cell Lymphoma

Business Wire July 18, 2016

bioMérieux – Second-Quarter 2016 Business Review

Business Wire July 18, 2016

bioMérieux – Information financière du 2e trimestre 2016

Business Wire July 18, 2016

Bpifrance accorde un prêt Innovation FEI (Fond Européen d’Investissement) pour financer le déploiement des produits innovants développés par Biosynex

Business Wire July 18, 2016

FDA Approves Genentech’s Xolair® (omalizumab) for Allergic Asthma in Children

Business Wire July 7, 2016

FDA Grants Priority Review for Genentech’s OCREVUS™ (ocrelizumab) Biologics License Application

Business Wire June 28, 2016

Roche receives FDA clearance for its Procalcitonin (PCT) assay to help clinicians effectively assess sepsis risk and manage sepsis patients

PR Newswire June 23, 2016